Wanbangde Pharmaceutical Holding Group Co Ltd (002082) — Cash Flow Reinvestment Rate
Wanbangde Pharmaceutical Holding Group Co Ltd (002082) has a Cash Flow Reinvestment Rate of 2.60x as of June 2025, reinvesting CN¥159.76 Million (capex CN¥153.03 Million plus investments CN¥6.73 Million) from operating cash flow of CN¥61.33 Million. Check Wanbangde Pharmaceutical Holding Group C cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Wanbangde Pharmaceutical Holding Group Co Ltd Cash Flow Reinvestment Rate (2003–2025)
Historical reinvestment intensity for Wanbangde Pharmaceutical Holding Group Co Ltd across 18 annual periods. Explore how well can Wanbangde Pharmaceutical Holding Group C service its debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Wanbangde Pharmaceutical Holding Group Co Ltd (2003–2025)
Year-by-year capital reinvestment analysis for Wanbangde Pharmaceutical Holding Group Co Ltd. For live market cap and broader valuation context, see market value of Wanbangde Pharmaceutical Holding Group C.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.49x | CN¥297.81 Million | CN¥603.98 Million | CN¥289.65 Million | ▼ -69.9% |
| 2024 | 1.64x | CN¥197.22 Million | CN¥120.22 Million | CN¥88.43 Million | ▼ -97.2% |
| 2021 | 57.80x | CN¥1.28 Billion | CN¥22.09 Million | CN¥277.06 Million | ▲ +1357.0% |
| 2020 | 3.97x | CN¥599.04 Million | CN¥151.01 Million | CN¥559.24 Million | ▲ +142.1% |
| 2018 | 1.64x | CN¥221.87 Million | CN¥135.40 Million | CN¥199.64 Million | ▲ +4926.7% |
| 2016 | 0.03x | CN¥10.13 Million | CN¥310.71 Million | CN¥9.03 Million | ▼ -98.2% |
| 2015 | 1.82x | CN¥30.47 Million | CN¥16.76 Million | CN¥30.47 Million | ▲ +467.9% |
| 2014 | 0.32x | CN¥44.91 Million | CN¥140.31 Million | CN¥44.91 Million | ▲ +502.5% |
| 2013 | 0.05x | CN¥12.45 Million | CN¥234.35 Million | CN¥12.45 Million | ▼ -73.7% |
| 2012 | 0.20x | CN¥40.92 Million | CN¥202.73 Million | CN¥40.92 Million | ▼ -25.6% |
| 2010 | 0.27x | CN¥44.02 Million | CN¥162.26 Million | CN¥44.02 Million | ▼ -69.2% |
| 2009 | 0.88x | CN¥60.02 Million | CN¥68.13 Million | CN¥60.02 Million | ▲ +51.7% |
| 2008 | 0.58x | CN¥146.92 Million | CN¥253.06 Million | CN¥146.92 Million | ▼ -93.4% |
| 2007 | 8.81x | CN¥109.68 Million | CN¥12.45 Million | CN¥109.68 Million | ▼ -67.0% |
| 2006 | 26.70x | CN¥93.47 Million | CN¥3.50 Million | CN¥93.47 Million | ▲ +241.2% |
| 2005 | 7.83x | CN¥87.86 Million | CN¥11.23 Million | CN¥87.86 Million | ▲ +160.2% |
| 2004 | 3.01x | CN¥98.30 Million | CN¥32.69 Million | CN¥98.30 Million | ▲ +193.5% |
| 2003 | 1.02x | CN¥37.92 Million | CN¥37.01 Million | CN¥37.92 Million | — |